National talks about drug equipment: no less than 30% for tertiary hospitals, and no less than 20% for tertiary and tertiary Chinese hospitals!

The dual-channel medical insurance policy has been implemented in various provinces one after another
.

Zhejiang took the lead in proposing the national talks about the variety allocation rate.

On November 2, Zhejiang Provincial Medical Security Bureau and Zhejiang Provincial Health Commission jointly issued the "Notice on Implementing the "Dual Channel" Management Mechanism for Drugs in National Medical Insurance Negotiations" and made interpretations
.

On April 22 this year, the National Medical Insurance Administration and the National Health Commission issued the "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for Drugs in National Medical Insurance Negotiations", clearly establishing and improving the "dual channel" management mechanism for drugs in the National Medical Insurance negotiation
.

It is required to implement classified management of nationally negotiated drugs to improve the level of supply security; select "dual-channel" management designated retail pharmacies to form a security joint force with medical institutions; improve payment policies and determine the level of adaptive security

On September 9, the National Medical Insurance Administration, in conjunction with the National Health Commission, issued the "Notice on Adapting to the Normalization of National Medical Insurance Negotiations and Continuing to Do a Good Job in the Implementation of Negotiated Drugs", requiring that the main responsibility of medical institutions be consolidated, policies and measures should be improved, and the "double" “Channel” management, etc.
, improve the level of drug supply guarantee for the national medical insurance negotiations
.

In this context, Zhejiang Province has also combined the actual conditions of the province and drafted the "Notice on Implementing the "Dual Channel" Management Mechanism for Drugs in the National Medical Insurance Negotiations" to ensure the smooth implementation of drugs under the National Medical Insurance Negotiations and better meet the needs of insured patients for rational drug use.

.

According to reports from "CCTV News" and "21st Century Pharmacy", the "dual channel" policy has not yet been implemented in most areas
.

In areas where pilot projects have begun, the number of drugs that can be paid for by medical insurance is far from covering more than 200 drugs negotiated by the state

In this regard, Jia Jie, the purchasing supervisor of a chain pharmacy in Beijing, believes that there may be a lot of problems.
Is it because the information network has not been uploaded, or the hospital has not actually uploaded the prescription? But anyway, there is no real flow of prescriptions from hospitals to retail pharmacies
.

According to Lu Baolin, the person in charge of a chain pharmacy in Beijing, some responsibilities are not clear during the implementation of the "dual channel" because the overall supporting policies are not particularly perfect.
The strict relationship chain between doctors, patients, hospitals, and pharmacies is currently It's not very clear either
.

According to analysis by industry insiders, the motivation for the circulation of prescriptions from hospitals comes from the restrictive assessment of the proportion of drugs in the medical insurance policy.
However, if the national drug is not within the scope of the assessment, then the official level of the hospital will have insufficient motivation for the circulation of prescriptions, or even do not want to transfer.
, Which also caused difficulties in the circulation of prescriptions
.

According to industry insiders, the establishment of a national prescription circulation platform as soon as possible has become the main starting point for promoting the implementation of the dual-channel policy as soon as possible
.

Chen Zhenwei, full-time vice president of the China Medical News Information Association, suggested that the percentage of prescriptions that doctors have each year should be assessed and transferred to retail pharmacies for sales.
If there is a certain percentage, the effect will be obvious
.

So, the document issued by Zhejiang Province this time clarifies the provision rate of Guotan medicines in hospitals and retail pharmacies, and may be able to solve this problem!

State talks drugs are included in Zhejiang Province's "dual channel" management

State talks drugs are included in Zhejiang Province's "dual channel" management

The notice pointed out that it is necessary to comprehensively consider factors such as clinical value and rational drug needs of patients, and implement "dual-channel" management of national drugs (including generic drugs and biosimilar drugs of the same generic name, the same below)
.

Guotan drugs are all included in Zhejiang Province’s “dual-channel” management, and a unified payment policy is implemented in designated medical institutions and designated retail pharmacies

Within three months after the announcement of the new version of the National Medical Insurance, the Pharmaceutical Affairs Committee shall be held in a timely manner, and the national talks about the "should be fully equipped" for drugs

Within three months after the announcement of the new version of the National Medical Insurance, the Pharmaceutical Affairs Committee shall be held in a timely manner, and the national talks about the "should be fully equipped" for drugs

The notice requires that all designated medical institutions should be equipped with and reasonably use national medicines in a timely manner in accordance with the functional positioning of the medical institution, clinical needs, diagnosis and treatment capabilities, and protocol requirements
.

Establish a linkage mechanism between the provision of hospital drugs and the adjustment of the medical insurance drug catalog.

According to the needs of diagnosis and treatment, in principle, the national drug product allocation rate shall not be less than 30% in the third- level A public comprehensive medical institutions , the third-level B public comprehensive medical institutions, and the third-level public Chinese medicine hospitals (including integrated traditional Chinese and Western medicine hospitals) shall not be less than 30% .
Less than 20%, and the third-level public specialist medical institutions shall not be less than 60% of the national medicines of the corresponding specialists
.

For medicines that are temporarily unavailable, it is necessary to establish a sound prescription circulation mechanism, and improve the availability of medicines through channels such as "dual channels"

No less than 30% for Grade 3 A public comprehensive medical institutions, Grade 3 B public comprehensive medical institutions, Grade 3 public Chinese medicine hospitals (including integrated Chinese and Western medicine hospitals) no less than 20%, and Grade 3 public specialist medical institutions no less than 20% Talk about 60% of the drug varieties in the corresponding specialist country

"Dual-channel" designated retail pharmacies, the national drug provision rate is not less than 30%

"Dual-channel" designated retail pharmacies, the national drug provision rate is not less than 30%

The notice also pointed out that all local medical insurance agencies must include qualified designated retail pharmacies under "dual-channel" management in accordance with regulations
.

Before the end of November 2021, in principle, ensure that there is at least one “dual-channel” pharmacy in the county (city, district) area, and the municipal district can increase the number appropriately

In principle, when Guotan drugs are used in outpatient clinics, they are not included in the total budget or converted into points for payment.

In principle, when Guotan drugs are used in outpatient clinics, they are not included in the total budget or converted into points for payment.

In light of the state-of-the-art drug use, reasonable adjustments will be made to the total annual medical insurance coverage of medical institutions to ensure the basic drug needs of patients
.

In principle, Guotan drugs are not included in the total budget or converted into points when used in outpatient clinics; during hospital use, the cost of drugs can be converted into points for payment or the points of the disease group can be reasonably adjusted according to the actual use of Guotan drugs

Not included in the assessment of the proportion of medicines in medical institutions and the average cost per time

Not included in the assessment of the proportion of medicines in medical institutions and the average cost per time

The health department should adjust and improve the evaluation mechanism for the use of drugs in medical institutions, and list the costs of rational use of drugs from the National Talks separately, and exclude them from the scope of evaluation indicators that affect their implementation, such as the proportion of drugs in medical institutions and the average cost per second
.
Strengthen the guidance and management of the clinical drug use behavior of designated medical institutions, and urge medical institutions in the jurisdiction to rationally allocate and use nationally negotiated drugs, and shall not influence the landing of nationally negotiated drugs on the grounds of total medical insurance restrictions, restrictions on the number of drugs used by medical institutions, and the proportion of drugs
.

Strengthen supervision and management to ensure the safety of medical insurance funds

Strengthen supervision and management to ensure the safety of medical insurance funds

Medical insurance agencies at all levels should improve the management of designated medical institutions agreement.
For designated medical institutions that fail to provide drugs as required, they should prompt, interview, rectify within a time limit, and terminate agreements.
At the same time, they should pay for the state of the drug provision and DRG points.
Evaluation, agreement management, annual assessment, etc.
are linked
.

Strengthen the management of the national talks on the use of drugs, refine the medical insurance drug review rules, strengthen intelligent monitoring, severely crack down on the fraudulent acquisition of medical insurance funds in the "dual channel" field, improve the monitoring mechanism for the use of national talks, and strengthen the provision, use and payment of national talks Statistical monitoring and evaluation of other situations
.